Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Xin Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3487-4892; OpenAlex author ID A5101453196. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 3 papers · 2024: none · 2025: 1 paper

Papers 6

  1. IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Co-author DOI 10.1016/j.celrep.2025.116476↗
  2. Elderly Pancreatic Adenocarcinoma Cancer Patients Could Benefit From Postoperative Chemotherapy. Last author DOI 10.1097/mpa.0000000000002214↗
  3. Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins. Co-author DOI 10.3389/fimmu.2023.1189161↗
  4. A case of pancreatic cancer treated with chemotherapy combined with immunotherapy and targeted therapy. Last author DOI 10.3724/zdxbyxb-2023-0258↗
  5. Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreati… Co-author DOI 10.1159/000489169↗
  6. Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.11.015↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yulian Wu · 4 shared papers, 2013–2025 · strength 0.65
  2. Kezhong Tang · 1 shared paper, 2023 · strength 0.31
  3. Bo Zhang · 1 shared paper, 2023 · strength 0.31
  4. Bin Xu · 2 shared papers, 2013–2023 · strength 0.27
  5. Wenjie Lu · 1 shared paper, 2023 · strength 0.24
  6. Qiaojun He · 1 shared paper, 2025 · strength 0.21
  7. Bo Yang · 1 shared paper, 2025 · strength 0.21
  8. Fujing Ge · 1 shared paper, 2025 · strength 0.21
  9. Liu Yang · 1 shared paper, 2025 · strength 0.21
  10. Xifeng Wu · 1 shared paper, 2023 · strength 0.17
  11. Xiawei Li · 1 shared paper, 2023 · strength 0.17
  12. Sai Pan · 1 shared paper, 2023 · strength 0.17
  13. Yu Wu · 1 shared paper, 2018 · strength 0.11
  14. Muxing Kang · 1 shared paper, 2013 · strength 0.03
  15. Qingqu Guo · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.